A startup founded to turn a landmark one-patient gene-editing success into a repeatable treatment has abandoned its lead program and cut staff roughly seven months after launching. Aurora Therapeutics, co-founded by Nobel laureate Jennifer Doudna and gene-editing researcher Fyodor Urnov, scrapped its lead program and cut staff, STAT reported. Aurora Therapeutics, a personalized gene-editing startup, scrapped its lead program and cut staff roughly seven months after launching in January 2026. What was the lead program? Avoid clinics offering gene therapy outside registered trials.